Follow
Susan Sharpe
Susan Sharpe
Verified email at moffitt.org
Title
Cited by
Cited by
Year
Cancer risk associated with nuclear atypia in cytologically indeterminate thyroid nodules: a systematic review and meta-analysis
P Valderrabano, L Khazai, ZJ Thompson, SC Sharpe, VD Tarasova, ...
Thyroid 28 (2), 210-219, 2018
572018
A brief report of toxicity end points of HeR2 vaccines for the treatment of patients with HeR2+ breast cancer
R Costa, S Zaman, S Sharpe, I Helenowski, C Shaw, H Han, H Soliman, ...
Drug design, development and therapy 13, 309, 2019
202019
Outcomes of repeat fineneedle aspiration biopsy for AUS/FLUS thyroid nodules
A Bayona, P Benavent, A Muriel, C Abuchaibe, SC Sharpe, V Tarasova, ...
European Journal of Endocrinology 185 (4), 497-506, 2021
192021
Meta-Analysis of Quality of Life in Cancer Patients Treated with Immune Checkpoint Inhibitors
BD Gonzalez, SL Eisel, KE Bowles, AI Hoogland, BW James, BJ Small, ...
JNCI: Journal of the National Cancer Institute, 2021
172021
A systematic review and meta-analysis of selected toxicity endpoints of alpelisib
M Shields, Q Mo, M Armitage, SC Sharpe, RLB Costa
Oncotarget 11 (42), 3793, 2020
112020
The system can't perform the operation now. Try again later.
Articles 1–5